2 Result: Immutep
Enveric Biosciences Soars on EVM201 Series Potential, Immutep Surges on Clinical Trial Findings, Buy Rating for IDEAYA Biosciences
May 24th, 2023
Enveric Biosciences, Inc. (Nasdaq: ENVB) said that has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for another patent application involving its EVM201 Series The soon-to-issue patent, titled "C4-Carbox. Read more
Immutep's Eftilagimod Alpha Shows Promise in Phase II Trial, Lightning eMotors Reports Q1 Loss and $50M Pre-Paid Advance Deal, BioNTech Upgraded to Buy
May 17th, 2023
Immutep Limited (Nasdaq: IMMP) has received positive feedback from the US Food and Drug Administration (FDA) for its late-stage clinical development plans for Eftilagimod Alpha ("efti") in the treatment of 1st line non-small cell lung cancer. In addi. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login